Navigation Links
Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
Date:1/31/2008

ancial position, results of operations, market position, product development and business strategy. These statements may be identified by the fact that they use words such as "anticipate", "estimates", "should", "expect", "guidance", "project", "intend", "plan", "believe" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, market factors, (including whether uncertainties in the credit and capital markets or a further deterioration of these markets will lead to future impairments to the company's investment portfolio) competitive product development, pricing controls and pressures (including changes in rules and practices of managed care groups and institutional and governmental purchasers), economic conditions such as interest rate and currency exchange rate fluctuations, judicial decisions and governmental laws and regulations related to Medicare, Medicaid and healthcare reform, pharmaceutical rebates and reimbursement, claims and concerns that may arise regarding the safety and efficacy of in- line products and product candidates, changes to wholesaler inventory levels, variability in data provided by third parties, changes in, and interpretation of, governmental regulations and legislation affecting domestic or foreign operations, including tax obligations, difficulties and delays in product development, manufacturing or sales, patent positions and the ultimate outcome of any litigation matter, including whether Apotex will prevail in its appeal of the District court's decision in the PLAVIX(R) patent litigation. These factors also include the company's ability to execute successfully
'/>"/>
SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
2. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
3. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
4. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
7. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
8. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
9. Bristol-Myers Squibb Announces Dividend
10. P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
11. First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... UK and The Gambia, have developed a new approach ... direct sequencing of DNA extracted from sputum (a technique ... cause TB without the need for time-consuming culture of ... today in the peer-reviewed journal PeerJ ... Microbial Genomics at Warwick Medical School and Dr Martin ...
(Date:9/23/2014)... CA (PRWEB) September 23, 2014 On September ... arrival of the most technically advanced horticultural LED grow light ... again with the XL750 and XL1000 , ... well as the experienced horticulturalist, because it has what the ... light spectrum. Kind LED's grower-tested 12 band spectrum (also known ...
(Date:9/23/2014)... September 23, 2014 Eight-week program, “Healing Female ... neuralgia, and other chronic pelvic or sexual pain, teaching intuitive ... According to the Gallup poll, 1 in 7 women between ... pain. Many of those women suffer in silence, finding ... The type of pain varies from woman to woman ...
(Date:9/23/2014)... The Nordic Times is a Non-commercial Liberal ... a Danish media company based in the heart of ... news, blogs, social feeds, and original content covering politics, ... from around the world. , The Nordic Times focuses ... way that virality has changed and shaped journalism in ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 According to ... Tough Mudder team just completed the Pittsburg 2014 ... course event that helps fund the wounded warrior project. ... Mudder team member, the ”Tough Mudder is an endurance ... course. Designed and created by British Special Forces to ...
Breaking Medicine News(10 mins):Health News:Researchers develop new DNA sequencing method to diagnose tuberculosis 2Health News:Kind LED K5 Series XL1000 Grow Lights Sell Out in Only 2 Days 2Health News:Mind Body Expert Launches Pelvic Pain Relief Program 2Health News:Launching of The Nordic Times, a new online newspaper and aggregator. 2
... between the two illnesses , , TUESDAY, May 26 (HealthDay ... and heart disease has been discovered by German scientists. ... (CHD) has been known for years, but a genetic ... of Kiel team found that the two diseases share ...
... than issues such as depression, anxiety, study finds ... attention problems in kindergarten often struggle academically right through ... led by Joshua Breslau of the University of California, ... show how attention problems early in a child,s life ...
... Conference Call Scheduled for Monday June 1 at 1:00 ... SAN FRANCISCO, Calif., May 26 Sunesis Pharmaceuticals, Inc. ... on the development and commercialization of new oncology therapeutics, ... ongoing Phase 2 clinical trials in frontline acute myeloid ...
... HealthLeaders-InterStudy Analyze Healthcare Market Drivers for the Nation,s ... NASHVILLE, Tenn., May 26 HealthLeaders-InterStudy, ... reports that safety-net hospitals in Atlanta and Cleveland ... burdens by charging uninsured residents outside of certain ...
... notes importance of regular oral care to protect areas that ... a 2008 Gallup-Healthways poll(1) show that 42 percent of Hispanics ... even though the American Dental Association recommends having regular check-ups ... all Americans responded that they did not see a dentist ...
... integrate our internal applications more robustly and cost-effectively, but also ... new interfaces within our timelines. , ... ... APC, a regional, high volume, radiology group in Seattle, Washington, ...
Cached Medicine News:Health News:Gum Disease, Heart Disease Share Genetic Link 2Health News:Attention Problems in Kindergarten Could Spell Long-Term Academic Trouble 2Health News:Attention Problems in Kindergarten Could Spell Long-Term Academic Trouble 3Health News:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO 2Health News:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO 3Health News:Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia and Ovarian Cancer Will Be Presented at ASCO 4Health News:Recession Fallout Leads Safety-Net Hospitals to Charge Out-of-County Residents for Non-Emergency Services 2Health News:Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care 2Health News:Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care 3Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 2Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 3Health News:Seattle Radiologists Raise Workflow Performance and Results with Corepoint Integration Engine 4
(Date:9/23/2014)... LONDON , September 23, 2014 ... pharmaceutical assets, announces the appointment of Jarrod ... role, Mr Longcor is responsible for structuring, negotiating ... financial investments, as well as providing management and ... member of the Executive leadership team. ...
(Date:9/22/2014)... 2014 , Cloud technology ... rigor for trial master file (TMF) accessibility and completeness ... survey to date reveals an increase in the number ... with remote access to their electronic trial master file ... the Veeva 2014 Paperless TMF Survey: An ...
(Date:9/22/2014)... 22, 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... to sell $200 million of its common stock in ... and BofA Merrill Lynch are acting as joint book-running ... a 30-day option to purchase additional shares of its ... in the offering are being sold by Avanir.  The ...
Breaking Medicine Technology:Avillion Appoints Jarrod Longcor as Chief Business Officer 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 2Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 3Remote eTMF Access to Double in 2015, Reveals Industry-wide Survey 4Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
Cold light source triple outlet....
Cold light source single outlet....
... 4150S is a state of ... light source with an integrated ... coupler to connect optical fiber ... distinguishes itself from all others ...
The 9300XSP is the brightest light source available. Visualize more clearly, see color more accurately, and work more effectively. Luxtecs xenon lighting delivers bright, white light that is as close...
Medicine Products: